Xijing Hospital
Clinical trials sponsored by Xijing Hospital, explained in plain language.
-
New balloon procedure tested as alternative to heart stents
Disease control CompletedThis study looked at how well a special drug-coated balloon works for treating blocked heart arteries in real-world patients. It involved 2,487 people who received this balloon treatment instead of a traditional drug-coated stent. Researchers wanted to see if this approach is saf…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug combo tested to shrink stomach tumors before surgery
Disease control CompletedThis study tested whether giving a combination of immunotherapy (tislelizumab) and chemotherapy (XELOX) before surgery could help people with advanced stomach or gastroesophageal junction cancer. It involved 28 patients to see if this approach safely shrank tumors and improved su…
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scarless tumor removal: how well does it work Long-Term?
Disease control CompletedThis study looked back at 700 patients who had minimally invasive endoscopic procedures to remove tumors in their digestive tract. Researchers wanted to see how effective these procedures were at completely removing tumors, what the risks were, and whether tumors came back over 5…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Scar-Reducing breast cancer surgery put to the test
Symptom relief CompletedThis study looked back at the medical records of 471 women who had breast cancer surgery with immediate reconstruction. It compared a newer, less invasive method using a tiny camera (endoscopic surgery) to the traditional method with a larger cut. The goal was to see which approa…
Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt for clues to personalize stomach cancer care
Knowledge-focused CompletedThis study aimed to find biological markers that could predict which patients with a type of stomach cancer would respond best to a specific treatment combination. Researchers observed 28 patients who received immunotherapy plus chemotherapy before surgery. They analyzed patient …
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists unlock secrets of why fatty donor livers fail more often
Knowledge-focused CompletedThis study aims to understand why liver transplants from donors with fatty liver disease are more vulnerable to damage after surgery. Researchers will analyze genetic data and medical records from 300 past transplant cases to identify which cells and genes are involved. The goal …
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:26 UTC